PXN and breast carcinoma: To overcome the barriers of cell permeability and nuclease-mediated degradation, the use of pH-sensitive carbonate apatite nanocarriers as delivery vehicles for the targeted delivery of paxillin RNAi has become an effective potential therapy for breast cancer [184].